Raymond James Financial’s Collegium Pharmaceutical COLL Stock Holding History

Raymond James Financial’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.54M	Sell	42,582 -2,891	-6%	-$98.8K	﹤0.01%	3689
2026 Q1	$1.5M	Sell	45,473 -8,119	-15%	-$344K	﹤0.01%	3565
2025 Q4	$2.48M	Buy	53,592 +8,177	+18%	+$342K	﹤0.01%	3094
2025 Q3	$1.59M	Buy	45,415 +4,373	+11%	+$152K	﹤0.01%	3343
2025 Q2	$1.21M	Sell	41,042 -33,478	-45%	-$955K	﹤0.01%	3445
2025 Q1	$2.22M	Sell	74,520 -10,363	-12%	-$317K	﹤0.01%	2911
2024 Q4	$2.43M	Buy	+84,883	New	+$2.81M	﹤0.01%	2829

Other funds holding COLL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Raymond James Financial's COLL Position: Q2 2026 in Review

Raymond James Financial reduced its Collegium Pharmaceutical (COLL) stake by 6.4% in Q2 2026, selling an estimated $98.8K and leaving 42,582 shares worth $1.54M. The position accounts for ﹤0.01% of the portfolio, ranked #3689.

Raymond James Financial first reported a position in COLL in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.48M in Q4 2025. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

Raymond James Financial held 42,582 shares of Collegium Pharmaceutical worth $1.54M as of Q2 2026.
Raymond James Financial sold 2,891 Collegium Pharmaceutical shares in Q2 2026, an estimated $98.8K.
Collegium Pharmaceutical made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #3689 holding.
Raymond James Financial first reported a position in Collegium Pharmaceutical in Q4 2024 and has held it in 7 quarters since.
Raymond James Financial's Collegium Pharmaceutical position peaked at $2.48M in Q4 2025.
279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.